Photo by impulsq from unsplash
had a IO PFS Click to show full abstract
had a IO PFS<2m; 14.7% of these patients stopped the treatment for toxicity. Among the 146 pts evaluable for response, PR was found in 23% of cases, SD in 30%, and PD in 47%.The table describe a comparison between two groups of QP during IO. Conclusion: In real life, QP during IO remains a challenge in NSCLC. Multivariate analyses will be presented to characterize these patients.
Keywords:
clinical relevance;
nsclc lymph;
incidence clinical;
relevance nsclc;
lymph node;
node micro
Journal Title: Journal of Thoracic Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Thoracic Oncology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!